THE EVOLVING ROLE OF CTDNA TO DETECT MINIMAL RESIDUAL DISEASE: IMPLICATIONS FOR THE MANAGEMENT OF COLORECTAL CANCER

September 15, 2021

Discuss the evolving role of circulating tumor DNA in the management of colorectal cancer.

Learning Objectives

Enhance knowledge of the role of CTDNA to Detect Minimal Residual Disease.

Course summary
Available credit: 
  • 1.00 ACPE - Pharmacist
  • 1.00 AMA PRA Category 1 Credit(s)
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)
Registration Opens: 
09/15/2021
Registration Expires: 
09/14/2022
Activity Starts: 
09/15/2021 - 12:00pm
Activity Ends: 
09/15/2021 - 1:00pm
Rating: 
0
Durham, NC 27705
United States

Available Credit

  • 1.00 ACPE - Pharmacist
  • 1.00 AMA PRA Category 1 Credit(s)
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)
Please login or register to take this course.